טוען...
Adherence to dipeptidyl peptidase‐4 inhibitor therapy among type 2 diabetes patients with employer‐sponsored health insurance in Japan
AIMS/INTRODUCTION: Dipeptidyl peptidase‐4 inhibitors (DPP‐4i) are a common first‐line treatment for type 2 diabetes in Japan. However, little is known about patients’ medication adherence, persistence and discontinuation in this setting. MATERIALS AND METHODS: This was a retrospective cohort study o...
שמור ב:
| הוצא לאור ב: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5009136/ https://ncbi.nlm.nih.gov/pubmed/27182033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12474 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|